Global Gastrointestinal Therapeutics Market to Grow at 4.5% During 2024-2032, Spurred by Increasing Incidences of Gastrointestinal Disorders

February 22, 2021 | Healthcare

According to the latest report by IMARC Group, titled "Gastrointestinal Therapeutics Market Report by Type (Branded, Generic), Route of Administration (Oral, Intravenous, and Others), Application (Ulcerative Colitis, Crohn's Disease, GERD, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032," the global gastrointestinal therapeutics market size reached US$ 46.5 Billion in 2023. Gastrointestinal disorders refer to medical conditions that are related to the gastrointestinal tract and the functioning of accessory digestive organs, such as the pancreas, stomach, small and large intestines, gall bladder and rectum. Some of the most common gastrointestinal disorders may include indigestion, constipation, peptic ulcer diseases, and irritable bowel syndrome, which are usually characterized by heartburn, stomachache, bloating, vomiting, and nausea. Gastrointestinal therapeutics is a branch of medicine that aids in the treatment of such ailments by reducing gastric acidity, improving digestion and properly regulating water flow in the gastrointestinal tract. These therapeutics include various over-the-counter (OTC) and prescription drugs, such as laxatives, antacids, antiemetics, antidiarrheal agents, and antiulcer agents.

Global Gastrointestinal Therapeutics Market Trends:

The global market is primarily driven by the rising prevalence of gastrointestinal diseases across the globe. Several ailments, such as constipation, diarrhea and gastroesophageal reflux disease (GERD), are commonly caused due to the shifting lifestyle preferences and the changing dietary patterns of the masses that have led to an increase in the consumption of unhealthy food. This, along with the rising healthcare expenditure, is providing a boost to the uptake of gastrointestinal therapeutics on the global level. Moreover, there has been a considerable rise in the geriatric population that is more prone to develop these gastrointestinal conditions. This, coupled with the easy availability of OTC gastrointestinal drugs through organized online and offline pharmacies, is expected to create a positive outlook for the market. The increasing usage of biosimilars and cellular therapies for the treatment of gastrointestinal disorders that offer personalized and targeted treatment to the patients is also creating a positive outlook for the market. Some of the other factors contributing to the market growth include the rising utilization of regenerative medicines, extensive research and development (R&D) activities, increasing numbers of clinical trials with accurate results to offer innovative therapies to the patients, and the significant developments in the overall healthcare infrastructure. On account of the aforementioned factors, the market is expected to grow at a CAGR of 4.5% during 2024-2032.

Market Summary:

  • On the basis of the type, the market has been bifurcated into branded and generic.
  • Based on the route of administration, the market has been divided into oral, intravenous, and others.
  • On the basis of the application, the market has been classified into ulcerative colitis, Crohn’s disease, GERD, and others.
  • Based on the distribution channel, the market has been segmented into hospital, retail and online pharmacies.
  • On the geographical front, the market has been segregated into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players include Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Bayer Aktiengesellschaft, GlaxoSmithKline Plc, Janssen Biotech Inc. (Johnson & Johnson), Novo Nordisk A/S, Pfizer Inc., Sanofi S.A., and Takeda Pharmaceuticals.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Type, Route of administration, Application, Distribution Channel, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Bayer Aktiengesellschaft, GlaxoSmithKline Plc, Janssen Biotech Inc. (Johnson & Johnson), Novo Nordisk A/S, Pfizer Inc., Sanofi S.A. and Takeda Pharmaceuticals.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Gastrointestinal Therapeutics Market to Grow at 4.5% During 2024-2032, Spurred by Increasing Incidences of Gastrointestinal Disorders
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More